CD226 and acute myeloid leukemia: There was an increase in the frequency of PD-1+/DNAM-1+ CD4+ and CD8+ T cells in AML recipients compared to naïve spleen, indicating an expansion of effector T cells with reduced cytotoxic potential (Fig. 3F, Supplementary Fig. 5A–D).